Translational Immunology Program News Today

Artizan Biosciences Selects Lead Product Candidate for Inflammatory Bowel Disease Therapeutic Development Program - read this article along with other careers information, tips and advice on BioSpace

NEW HAVEN, Conn., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Artizan Biosciences, Inc. (“Artizan”), a precision medicine biotechnology company, today announced the selection of its lead product candidate, ARZC-001, for the

The startling discovery by Yale researchers and their co-authors stands in contrast to the longheld belief that insulin production is unique to the pancreas.